Literature DB >> 30131304

Challenges and Technological Trends Toward Improved Medical Imaging-based Predictive Data-mining.

Assaf Zaritsky1.   

Abstract

Entities:  

Keywords:  Data-mining; Deep learning; Medical imaging; Radiomics

Mesh:

Year:  2018        PMID: 30131304      PMCID: PMC6161535          DOI: 10.1016/j.ebiom.2018.08.017

Source DB:  PubMed          Journal:  EBioMedicine        ISSN: 2352-3964            Impact factor:   8.143


× No keyword cloud information.
Osteosarcoma is the most common form of bone cancers, with 5-year survival rate of about 60% [1]. In this issue of EBioMedicine, Wu et al. developed a computational method to predict personalized 5 years-survival status from Computed Tomography (CT) scans of high grade osteosarcoma imaged at the time of diagnosis [11]. By extracting hundreds of numbers (features) from each CT scan, they trained a machine-learning predictive model and validated its performance using information from 150 patients imaged in their institution. This study has followed the footsteps of previous studies that used similar approaches. For example, to predict lymph node metastasis in colorectal cancer [2], prognosis-associated biomarkers in non–small cell lung cancer [3], and survival in non–small cell lung cancer [4]. Such computational-based conversion of medical images to high-dimensional quantitative representations, and their use to identify patterns in such datasets is termed Radiomics, and has great potential to impact cancer detection, diagnosis, treatment and prognosis [5]. Many challenges face toward making Radiomics more effective in the clinic: change of culture, bureaucracy matters and methodology. Here, I briefly discuss several opportunities to improve the technical/methodological aspects that can drive forward the field. First, it is important to recognize the existence of a community of computer scientists and engineers that apply computer vision to medical imaging. Researchers in this community have their own venues to present and publish their research (e.g., MICCAI, ISBI) and peer-assessment is mostly aimed toward algorithmic novelty and surpassing state-of-the art performance with some, but not sufficient, focus on the clinical relevance. Bridging these gaps between the clinicians and computational scientists is key in advancing the field. Accordingly, efforts for synergetic collaborative projects are becoming more common in recent years (for example, the MICCAI challenges [6] and http://miccai.cloudapp.net/competitions/84). Deep learning has emerged as a promising method to extract information from images [7]. Its success stems from the idea of optimizing the feature-representation of an image - moving away from manually-engineered to automatic- and application-specific feature extraction. Such approach requires “big data” to train robust models that can generalize well to capture the essence of the data, an aspect that is mostly lacking from patient-derived imaging data where collection of large datasets is complicated and expensive. This limitation can be resolved with transfer learning, modifying existing models, trained for another purpose, by retraining them with the specific data of interest [8]. This approach already proven success in the realm of medical imaging, even when the initial model was trained on non-medical images [9]. Another promising opportunity lies in data integration across different sources, containing complementary information, to enhance performance and predictive accuracy. Wu et al. demonstrated that combining CT-derived features with clinical factors outperforms models trained using each of these sources of information separately [11]. This conclusion was previously confirmed by others, including Grossmann et al. [10] who convincingly demonstrated integration of radiomics (CT), genetic, and clinical information. Advanced computational methods can be exceedingly beneficial to extract more predictive information by data-fusion of imaging modalities, genomics and clinical data. Making medical images publicaly available is critical for rapid technological advancements. This approach has proven success for omics-data, where the field of bioinformatics emerged on the grounds of large-scale collection of data, openly disseminated according to the FAIR principles - findable, accessible, interoperable, and reusable. This is even more complicated for medical imaging due to privacy issues, large scale, plethora of imaging technologies, data formats, and variability in imaging protocols between clinicians and institutions. Metadata harmonization and organization is key for effective data deposition, dissemination and retrieval, and can be achieved through multi-disciplinary community-driven standardization efforts between clinicians, academics, industrial and regulatory representatives. Large repositories must be built to host large-scale medical image data from multiple institutions. To fully exploit the clinical potential, the image data should be accompanied by the corresponding clinical information, diagnosis, prognosis, and eventual outcome, when available. Funding this expensive infrastructure should be via public funding agencies and private philanthropy. The availability of such massive datasets is essential to fully exploit the information encapsulated in medical images, and indeed, efforts in this direction are just beginning to sprout (e.g., http://www.cancerimagingarchive.net/, https://aimi.stanford.edu/medical-imagenet). It will be important to assess the variability and batch-effects within and between different imaging modalities, protocols and institutions as a first step toward data harmonization, integration and knowledge-retrieval. Radiomics has the potential to significantly improve diagnosis and personalized care of cancer patients. Bridging the gap between the clinical and computational community toward synergetic efforts is necessary to tackle the technical challenges and will eventually lead to improved care routinely practiced in the clinic. The author declares no conflicts of interest.
  8 in total

1.  Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.

Authors:  Olivier Gevaert; Jiajing Xu; Chuong D Hoang; Ann N Leung; Yue Xu; Andrew Quon; Daniel L Rubin; Sandy Napel; Sylvia K Plevritis
Journal:  Radiology       Date:  2012-06-21       Impact factor: 11.105

2.  The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer.

Authors:  Kald Abdallah; Charles Hugh-Jones; Thea Norman; Stephen Friend; Gustavo Stolovitzky
Journal:  Oncologist       Date:  2015-03-16

3.  Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.

Authors:  Yanqi Huang; Zaiyi Liu; Lan He; Xin Chen; Dan Pan; Zelan Ma; Cuishan Liang; Jie Tian; Changhong Liang
Journal:  Radiology       Date:  2016-06-27       Impact factor: 11.105

4.  Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer.

Authors:  Yan-Qi Huang; Chang-Hong Liang; Lan He; Jie Tian; Cui-Shan Liang; Xin Chen; Ze-Lan Ma; Zai-Yi Liu
Journal:  J Clin Oncol       Date:  2016-05-02       Impact factor: 44.544

5.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

6.  Defining the biological basis of radiomic phenotypes in lung cancer.

Authors:  Patrick Grossmann; Olya Stringfield; Nehme El-Hachem; Marilyn M Bui; Emmanuel Rios Velazquez; Chintan Parmar; Ralph Th Leijenaar; Benjamin Haibe-Kains; Philippe Lambin; Robert J Gillies; Hugo Jwl Aerts
Journal:  Elife       Date:  2017-07-21       Impact factor: 8.140

Review 7.  Imaging biomarker roadmap for cancer studies.

Authors:  James P B O'Connor; Eric O Aboagye; Judith E Adams; Hugo J W L Aerts; Sally F Barrington; Ambros J Beer; Ronald Boellaard; Sarah E Bohndiek; Michael Brady; Gina Brown; David L Buckley; Thomas L Chenevert; Laurence P Clarke; Sandra Collette; Gary J Cook; Nandita M deSouza; John C Dickson; Caroline Dive; Jeffrey L Evelhoch; Corinne Faivre-Finn; Ferdia A Gallagher; Fiona J Gilbert; Robert J Gillies; Vicky Goh; John R Griffiths; Ashley M Groves; Steve Halligan; Adrian L Harris; David J Hawkes; Otto S Hoekstra; Erich P Huang; Brian F Hutton; Edward F Jackson; Gordon C Jayson; Andrew Jones; Dow-Mu Koh; Denis Lacombe; Philippe Lambin; Nathalie Lassau; Martin O Leach; Ting-Yim Lee; Edward L Leen; Jason S Lewis; Yan Liu; Mark F Lythgoe; Prakash Manoharan; Ross J Maxwell; Kenneth A Miles; Bruno Morgan; Steve Morris; Tony Ng; Anwar R Padhani; Geoff J M Parker; Mike Partridge; Arvind P Pathak; Andrew C Peet; Shonit Punwani; Andrew R Reynolds; Simon P Robinson; Lalitha K Shankar; Ricky A Sharma; Dmitry Soloviev; Sigrid Stroobants; Daniel C Sullivan; Stuart A Taylor; Paul S Tofts; Gillian M Tozer; Marcel van Herk; Simon Walker-Samuel; James Wason; Kaye J Williams; Paul Workman; Thomas E Yankeelov; Kevin M Brindle; Lisa M McShane; Alan Jackson; John C Waterton
Journal:  Nat Rev Clin Oncol       Date:  2016-10-11       Impact factor: 66.675

8.  Survival Prediction in High-grade Osteosarcoma Using Radiomics of Diagnostic Computed Tomography.

Authors:  Yan Wu; Lei Xu; Pengfei Yang; Nong Lin; Xin Huang; Weibo Pan; Hengyuan Li; Peng Lin; Binghao Li; Varitsara Bunpetch; Chen Luo; Yangkang Jiang; Disheng Yang; Mi Huang; Tianye Niu; Zhaoming Ye
Journal:  EBioMedicine       Date:  2018-07-17       Impact factor: 8.143

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.